208 related articles for article (PubMed ID: 34427052)
1. A 24-month metformin treatment study of children with obesity: Changes in circulating GDF-15 and associations with changes in body weight and visceral fat.
Carreras-Badosa G; Gómez-Vilarrubla A; Mas-Parés B; Martínez-Calcerrada JM; Xargay-Torrent S; Prats-Puig A; Puerto-Carranza E; Díaz-Roldán F; de Zegher F; Ibañez L; Bassols J; López-Bermejo A
Pediatr Obes; 2022 Feb; 17(2):e12845. PubMed ID: 34427052
[TBL] [Abstract][Full Text] [Related]
2. Effects of metformin administration on endocrine-metabolic parameters, visceral adiposity and cardiovascular risk factors in children with obesity and risk markers for metabolic syndrome: A pilot study.
Bassols J; Martínez-Calcerrada JM; Osiniri I; Díaz-Roldán F; Xargay-Torrent S; Mas-Parés B; Dorado-Ceballos E; Prats-Puig A; Carreras-Badosa G; de Zegher F; Ibáñez L; López-Bermejo A
PLoS One; 2019; 14(12):e0226303. PubMed ID: 31821361
[TBL] [Abstract][Full Text] [Related]
3. Metformin treatment to reduce central adiposity after prenatal growth restraint: a placebo-controlled pilot study in prepubertal children.
Díaz M; Bassols J; López-Bermejo A; de Zegher F; Ibáñez L
Pediatr Diabetes; 2015 Nov; 16(7):538-45. PubMed ID: 25332100
[TBL] [Abstract][Full Text] [Related]
4. Metformin for Obesity in Prepubertal and Pubertal Children: A Randomized Controlled Trial.
Pastor-Villaescusa B; Cañete MD; Caballero-Villarraso J; Hoyos R; Latorre M; Vázquez-Cobela R; Plaza-Díaz J; Maldonado J; Bueno G; Leis R; Gil Á; Cañete R; Aguilera CM
Pediatrics; 2017 Jul; 140(1):. PubMed ID: 28759403
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of differential effects of metformin treatment in obese children according to pubertal stage and genetic variations: study protocol for a randomized controlled trial.
Pastor-Villaescusa B; Caballero-Villarraso J; Cañete MD; Hoyos R; Maldonado J; Bueno G; Leis R; Gil Á; Cañete R; Aguilera CM
Trials; 2016 Jul; 17(1):323. PubMed ID: 27432166
[TBL] [Abstract][Full Text] [Related]
6. Circulating total and intact GDF-15 levels are not altered in response to weight loss induced by liraglutide or lorcaserin treatment in humans with obesity.
Valenzuela-Vallejo L; Chrysafi P; Bello-Ramos J; Bsata S; Mantzoros CS
Metabolism; 2022 Aug; 133():155237. PubMed ID: 35700837
[TBL] [Abstract][Full Text] [Related]
7. Circulating GDF15 concentrations in girls with low birth weight: effects of prolonged metformin treatment.
Díaz M; Carreras-Badosa G; Villarroya J; Gavaldà-Navarro A; Bassols J; de Zegher F; López-Bermejo A; Villarroya F; Ibáñez L
Pediatr Res; 2023 Mar; 93(4):964-968. PubMed ID: 35817957
[TBL] [Abstract][Full Text] [Related]
8. Drug interventions for the treatment of obesity in children and adolescents.
Mead E; Atkinson G; Richter B; Metzendorf MI; Baur L; Finer N; Corpeleijn E; O'Malley C; Ells LJ
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012436. PubMed ID: 27899001
[TBL] [Abstract][Full Text] [Related]
9. Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial.
Yanovski JA; Krakoff J; Salaita CG; McDuffie JR; Kozlosky M; Sebring NG; Reynolds JC; Brady SM; Calis KA
Diabetes; 2011 Feb; 60(2):477-85. PubMed ID: 21228310
[TBL] [Abstract][Full Text] [Related]
10. Maternal body mass index, gestational weight gain, and childhood abdominal, pericardial, and liver fat assessed by magnetic resonance imaging.
Santos S; Monnereau C; Felix JF; Duijts L; Gaillard R; Jaddoe VWV
Int J Obes (Lond); 2019 Mar; 43(3):581-593. PubMed ID: 30232419
[TBL] [Abstract][Full Text] [Related]
11. Effects of metformin on energy intake and satiety in obese children.
Adeyemo MA; McDuffie JR; Kozlosky M; Krakoff J; Calis KA; Brady SM; Yanovski JA
Diabetes Obes Metab; 2015 Apr; 17(4):363-70. PubMed ID: 25483291
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the gut microbiota after metformin intervention in children with obesity: A metagenomic study of a randomized controlled trial.
Pastor-Villaescusa B; Plaza-Díaz J; Egea-Zorrilla A; Leis R; Bueno G; Hoyos R; Vázquez-Cobela R; Latorre M; Cañete MD; Caballero-Villarraso J; Gil Á; Cañete R; Aguilera CM
Biomed Pharmacother; 2021 Feb; 134():111117. PubMed ID: 33360047
[TBL] [Abstract][Full Text] [Related]
13. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
14. Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit.
Casteels K; Fieuws S; van Helvoirt M; Verpoorten C; Goemans N; Coudyzer W; Loeckx D; de Zegher F
Pediatr Diabetes; 2010 Feb; 11(1):61-9. PubMed ID: 19496972
[TBL] [Abstract][Full Text] [Related]
15. Metformin in the Management of Childhood Obesity: A Randomized Control Trial.
Warnakulasuriya LS; Fernando MMA; Adikaram AVN; Thawfeek ARM; Anurasiri WL; Silva RR; Sirasa MSF; Rytter E; Forslund AH; Samaranayake DL; Wickramasinghe VP
Child Obes; 2018; 14(8):553-565. PubMed ID: 30070925
[TBL] [Abstract][Full Text] [Related]
16. Two-Year Treatment With Metformin During Puberty Does Not Preserve β-Cell Function in Youth With Obesity.
Kelsey MM; Hilkin A; Pyle L; Severn C; Utzschneider K; Van Pelt RE; Zeitler PS; Nadeau KJ
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2622-e2632. PubMed ID: 33728428
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.
Martinez JA; Chalasani P; Thomson CA; Roe D; Altbach M; Galons JP; Stopeck A; Thompson PA; Villa-Guillen DE; Chow HH
BMC Cancer; 2016 Jul; 16():500. PubMed ID: 27430256
[TBL] [Abstract][Full Text] [Related]
18. Metformin Therapy Reduces Obesity Indices in Children and Adolescents: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Sadeghi A; Mousavi SM; Mokhtari T; Parohan M; Milajerdi A
Child Obes; 2020 Apr; 16(3):174-191. PubMed ID: 32068434
[No Abstract] [Full Text] [Related]
19. Growth differentiation factor 15 predicts future insulin resistance and impaired glucose control in obese nondiabetic individuals: results from the XENDOS trial.
Kempf T; Guba-Quint A; Torgerson J; Magnone MC; Haefliger C; Bobadilla M; Wollert KC
Eur J Endocrinol; 2012 Nov; 167(5):671-8. PubMed ID: 22918303
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Lipase Inhibitor Orlistat in Japanese with Excessive Visceral Fat Accumulation: 24-Week, Double-Blind, Randomized, Placebo-Controlled Study.
Shirai K; Fujita T; Tanaka M; Fujii Y; Shimomasuda M; Sakai S; Samukawa Y
Adv Ther; 2019 Jan; 36(1):86-100. PubMed ID: 30535651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
